Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.

Eric Black-MaierSunghee KimBenjamin Adam Steinberg Gregory Y H LipJames V FreemanPeter R KoweyJack AnsellBernard J GershKenneth W MahaffeyGerald NaccarelliElaine M HylekAlan S GoEric D PetersonJonathan P Piccininull null

Published in: Clinical cardiology (2017)

Management of anticoagulation among AF patients undergoing CIED implantation is highly variable, with OAC being interrupted in more than half of both warfarin- and NOAC-treated patients. Bleeding and stroke events were infrequent in both warfarin and NOAC-treated patients.

Keyphrases

atrial fibrillation
end stage renal disease
newly diagnosed
venous thromboembolism
ejection fraction
patients undergoing
chronic kidney disease
oral anticoagulants
peritoneal dialysis
prognostic factors
heart failure
left ventricular
patient reported outcomes
subarachnoid hemorrhage